Banque Cantonale Vaudoise’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SFCM
Banque Cantonale Vaudoise's MTRI Position: Q3 2026 in Review
Banque Cantonale Vaudoise held its Mentari Therapeutics, Inc. Common Stock (MTRI) position steady in Q3 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #883.
Banque Cantonale Vaudoise first reported a position in MTRI in Q3 2024 and has held it in 8 quarters since. The position peaked at $1K in Q2 2026. 16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.
- Banque Cantonale Vaudoise held 1 share of Mentari Therapeutics, Inc. Common Stock worth $0 as of Q3 2026.
- Banque Cantonale Vaudoise left its Mentari Therapeutics, Inc. Common Stock share count unchanged in Q3 2026.
- Mentari Therapeutics, Inc. Common Stock made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q3 2026, its #883 holding.
- Banque Cantonale Vaudoise first reported a position in Mentari Therapeutics, Inc. Common Stock in Q3 2024 and has held it in 8 quarters since.
- Banque Cantonale Vaudoise's Mentari Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2026.
- 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.
Based on Banque Cantonale Vaudoise's 13F filing for Q3 2026, filed 12 Nov 2026.